$RGLS
Regulus Therapeutics Inc. Stock $rgls

$rgls Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000162828019013991 Filed on November 12, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q4
Revenue	$18.00K	$18.00K	$18.00K
YoY Change	0.0%	0.0%	0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.360M	$2.570M	$2.750M
YoY Change	-14.18%	-14.05%	-15.64%
% of Gross Profit
Research & Development	$1.970M	$2.440M	$5.260M
YoY Change	-62.55%	-64.53%	-49.76%
% of Gross Profit
Depreciation & Amortization	$130.0K	$130.0K	$590.0K
YoY Change	-77.97%	-76.36%	1.72%
% of Gross Profit
Operating Expenses	$4.453M	$5.011M	$8.000M
YoY Change	-44.34%	-49.24%	-41.71%
Operating Profit		-$4.993M
YoY Change		-49.33%
Interest Expense	-$460.0K	$517.0K	-$520.0K
YoY Change	-11.54%	-16.61%	-35.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$4.890M	-$5.423M	-$8.500M
YoY Change	-42.47%	-47.21%	-41.42%
Income Tax	$0.00	$0.00	$60.00K
% Of Pretax Income
Net Earnings	-$4.893M	-$5.423M	-$8.563M
YoY Change	-42.86%	-47.21%	-40.73%
Net Earnings / Revenue	-27183.33%	-30127.78%	-47572.22%
Basic Earnings Per Share
Diluted Earnings Per Share	-$233.0K	-$260.0K	-$971.6K
COMMON SHARES
Basic Shares Outstanding	20.93M shares	20.82M shares	8.750M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.10M	$14.60M	$13.90M
YoY Change	145.32%	-28.78%	-76.87%
Cash & Equivalents	$34.12M	$14.65M	$13.94M
Short-Term Investments			$0.00
Other Short-Term Assets	$1.221M	$358.0K	$1.140M
YoY Change	7.11%	-50.07%	-24.3%
Inventory
Prepaid Expenses	$3.924M	$3.826M	$4.194M
Receivables	$1.100M	$700.0K	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$40.41M	$19.53M	$19.30M
YoY Change	109.42%	-23.24%	-71.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$921.0K	$1.042M	$7.806M
YoY Change	-88.2%	-87.48%	-19.59%
Goodwill
YoY Change
Intangibles	$266.0K	$303.0K	$500.0K
YoY Change	-46.8%	-55.18%	-35.48%
Long-Term Investments
YoY Change
Other Assets	$487.0K	$536.0K	$326.0K
YoY Change	49.39%	63.91%	-44.75%
Total Long-Term Assets	$1.674M	$1.881M	$8.632M
YoY Change	-80.61%	-79.83%	-22.04%
TOTAL ASSETS
Total Short-Term Assets	$40.41M	$19.53M	$19.30M
Total Long-Term Assets	$1.674M	$1.881M	$8.632M
Total Assets	$42.08M	$21.41M	$27.93M
YoY Change	50.68%	-38.42%	-64.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.321M	$1.521M	$1.714M
YoY Change	-22.93%	23.16%	-70.15%
Accrued Expenses	$770.0K	$1.212M	$1.625M
YoY Change	-52.62%	-34.7%	-67.11%
Deferred Revenue	$6.000K	$24.00K	$2.572M
YoY Change	-99.77%	-66.67%	3472.22%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$14.90M	$14.90M	$16.60M
YoY Change	-10.24%	-21.99%	-16.58%
Total Short-Term Liabilities	$21.60M	$21.00M	$26.65M
YoY Change	-18.94%	-18.13%	-18.26%
LONG-TERM LIABILITIES
Long-Term Debt	$100.0K	$100.0K	$0.00
YoY Change
Other Long-Term Liabilities	$468.0K	$549.0K	$309.0K
YoY Change	51.46%	47.18%
Total Long-Term Liabilities	$468.0K	$549.0K	$309.0K
YoY Change	51.46%	47.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.60M	$21.00M	$26.65M
Total Long-Term Liabilities	$468.0K	$549.0K	$309.0K
Total Liabilities	$22.07M	$21.55M	$33.78M
YoY Change	-34.68%	-35.06%	-20.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$411.3M	-$406.4M	-$392.7M
YoY Change	4.73%	5.79%	13.55%
Common Stock	$431.3M	$406.3M	$386.9M
YoY Change	11.49%	5.31%	1.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.02M	-$143.0K	-$5.854M
YoY Change
Total Liabilities & Shareholders Equity	$42.08M	$21.41M	$27.93M
YoY Change	50.68%	-38.42%	-64.11%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q4
OPERATING ACTIVITIES
Net Income	-$4.893M	-$5.423M	-$8.563M
YoY Change	-42.86%	-47.21%	-40.73%
Depreciation, Depletion And Amortization	$130.0K	$130.0K	$590.0K
YoY Change	-77.97%	-76.36%	1.72%
Cash From Operating Activities	-$4.980M	-$4.720M	-$4.010M
YoY Change	24.19%	-58.78%	-63.87%
INVESTING ACTIVITIES
Capital Expenditures	-$60.00K	-$160.0K	$0.00
YoY Change		700.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$30.00K	$6.440M
YoY Change	-100.0%	-99.77%	43.75%
Cash From Investing Activities	-$60.00K	-$140.0K	$6.440M
YoY Change	-100.93%	-101.08%	46.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	24.51M	-70.00K	-2.570M
YoY Change	-1053.7%	-92.13%
NET CHANGE
Cash From Operating Activities	-4.980M	-4.720M	-4.010M
Cash From Investing Activities	-60.00K	-140.0K	6.440M
Cash From Financing Activities	24.51M	-70.00K	-2.570M
Net Change In Cash	19.47M	-4.930M	-140.0K
YoY Change	-14007.14%	-935.59%	-97.91%
FREE CASH FLOW
Cash From Operating Activities	-$4.980M	-$4.720M	-$4.010M
Capital Expenditures	-$60.00K	-$160.0K	$0.00
Free Cash Flow	-$4.920M	-$4.560M	-$4.010M
YoY Change	22.69%	-60.1%	-63.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001505512
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20927053	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2019Q3	dei	Entity Number Of Employees EntityNumberOfEmployees	21	employee
CY2019Q3	rgls	Lease Liabilities LeaseLiabilities	1262000	USD
CY2019Q1	rgls	Lease Payments Eliminated LeasePaymentsEliminated	14400000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Entity Registrant Name EntityRegistrantName	REGULUS THERAPEUTICS INC.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q1	rgls	Accumulated Other Comprehensive Income Loss Unrealized Gainon Short Term Investments AccumulatedOtherComprehensiveIncomeLossUnrealizedGainonShortTermInvestments	7000	USD
CY2018Q2	rgls	Accumulated Other Comprehensive Income Loss Unrealized Gainon Short Term Investments AccumulatedOtherComprehensiveIncomeLossUnrealizedGainonShortTermInvestments	47000	USD
CY2018Q3	rgls	Accumulated Other Comprehensive Income Loss Unrealized Gainon Short Term Investments AccumulatedOtherComprehensiveIncomeLossUnrealizedGainonShortTermInvestments	16000	USD
CY2019Q3	rgls	Cashand Cash Equivalentsand Marketable Securities CashandCashEquivalentsandMarketableSecurities	14600000	USD
	rgls	Gainon Reductionof Lease Liability GainonReductionofLeaseLiability	0	USD
	rgls	Gainon Reductionof Lease Liability GainonReductionofLeaseLiability	1839000	USD
CY2019Q3	rgls	Lease Right Of Use Asset LeaseRightOfUseAsset	1022000	USD
	rgls	Noncash Gain Dueto Reductionof Lease Liability NoncashGainDuetoReductionofLeaseLiability	1300000	USD
CY2018Q4	rgls	Numberof Optionholders NumberofOptionholders	31	optionholder
CY2019Q3	rgls	Operatingand Finance Lease Payments OperatingandFinanceLeasePayments	72000	USD
	rgls	Operatingand Finance Lease Payments OperatingandFinanceLeasePayments	866000	USD
	rgls	Paymentson Finance Leases PaymentsonFinanceLeases	138000	USD
	rgls	Paymentson Finance Leases PaymentsonFinanceLeases	196000	USD
	rgls	Proceeds From Finance Leases ProceedsFromFinanceLeases	492000	USD
	rgls	Proceeds From Finance Leases ProceedsFromFinanceLeases	0	USD
	rgls	Proceeds Paymentsfrom Saleand Acquisitionof Property Plantand Equipment Net ProceedsPaymentsfromSaleandAcquisitionofPropertyPlantandEquipmentNet	0	USD
	rgls	Proceeds Paymentsfrom Saleand Acquisitionof Property Plantand Equipment Net ProceedsPaymentsfromSaleandAcquisitionofPropertyPlantandEquipmentNet	318000	USD
CY2018Q4	rgls	Rent Less Current Portion Liability RentLessCurrentPortionLiability	6820000	USD
CY2019Q3	rgls	Rent Less Current Portion Liability RentLessCurrentPortionLiability	0	USD
CY2018Q4	rgls	Share Based Eligible Exchange Offer Shares ShareBasedEligibleExchangeOfferShares	915009	shares
CY2019Q2	rgls	Stock Issued During Period Shares Preferred Stock Warants From Private Placement Netof Offering Costs Value StockIssuedDuringPeriodSharesPreferredStockWarantsFromPrivatePlacementNetofOfferingCostsValue	15505000	USD
CY2016Q4	rgls	Tenant Improvement Allowance TenantImprovementAllowance	8200000	USD
CY2018Q4	rgls	Upfront Payment Received UpfrontPaymentReceived	2500000	USD
CY2019Q1	rgls	Upfront Payment Received UpfrontPaymentReceived	1800000	USD
CY2018Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	26000	USD
CY2019Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	699000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1672000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	800000	USD
	rgls	Noncash Leasehold Improvements NoncashLeaseholdImprovements	5600000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1714000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1625000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1212000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	386860000	USD
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	406258000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1627000	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1357000	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1390000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1521000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-92000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	959000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	321000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	536000	USD
CY2018Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1390000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4374000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	536000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1816000	USD
CY2018Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	575256	shares
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4158980	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2224216	shares
CY2018Q4	us-gaap	Assets Assets	27927000	USD
CY2019Q3	us-gaap	Assets Assets	21410000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	19295000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	19529000	USD
CY2018Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	11173000	USD
CY2019Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	14365000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13935000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14646000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13519000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14084000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13935000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14646000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	565000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	711000	USD
CY2019Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13890000	shares
CY2019Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	21964000	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8818019	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20927053	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8818019	shares
CY2019Q3	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	900000	USD
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20927053	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10257000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-40076000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5423000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13699000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2572000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	24000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	6000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	1843000	USD
CY2018Q4	us-gaap	Debt Current DebtCurrent	16575000	USD
CY2019Q3	us-gaap	Debt Current DebtCurrent	14626000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.18
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.62
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.86
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1601000	USD
CY2019Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	925000	USD
CY2019Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	6000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	19000	USD
CY2019Q3	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	6000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	19000	USD
CY2019Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	401000	USD
CY2019Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	600000	USD
CY2019Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	287000	USD
CY2019Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	114000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	416000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	57000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	287000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	72000	USD
CY2019Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	15000	USD
CY2019Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	66000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	196000	USD
CY2019Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	512000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	600000	USD
CY2019Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	46000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	137000	USD
CY2019Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.049
CY2019Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-1600000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2993000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10115000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4374000	USD
CY2015Q3	us-gaap	Incentive From Lessor IncentiveFromLessor	1400000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2571000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8954000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1816000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10273000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40146000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5423000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13698000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-360000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	673000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4509000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-193000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1138000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-473000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-54000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2554000	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-933000	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	0	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-693000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-676000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1050000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-572000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-102000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2233000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-589000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-368000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	500000	USD
CY2019Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	303000	USD
CY2018Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	201000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	483000	USD
CY2019Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	87000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	332000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	620000	USD
	us-gaap	Interest Expense InterestExpense	1848000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	517000	USD
	us-gaap	Interest Expense InterestExpense	1631000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1573000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1263000	USD
CY2019Q3	us-gaap	Lease Cost LeaseCost	122000	USD
	us-gaap	Lease Cost LeaseCost	801000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	977000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	442000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	429000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	106000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	116000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	306000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	61000	USD
CY2015Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P96M
CY2015Q3	us-gaap	Net Rentable Area NetRentableArea	59248	sqft
CY2018Q4	us-gaap	Liabilities Liabilities	33781000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	21553000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-40146000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-3260000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-5016000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-5423000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13699000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27927000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21410000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	26646000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	21004000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-258000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15422000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	40079000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	133000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-39256000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14844000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-16025000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-13847000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-10273000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	9872000	USD
	us-gaap	Operating Expenses OperatingExpenses	38835000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	5011000	USD
	us-gaap	Operating Expenses OperatingExpenses	19213000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-9854000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-38781000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4993000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12399000	USD
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	70000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	645000	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	861000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	11300000	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	349000	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	512000	USD
CY2019Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	0	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	651000	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	510000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3300000	USD
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.109
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1140000	USD
CY2019Q3	us-gaap	Other Assets Current OtherAssetsCurrent	358000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	326000	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	536000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	16000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	70000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2559000	USD
CY2019Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2696000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	309000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	549000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	182000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	262000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	23000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	162000	USD
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	415898	shares
CY2019Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	415898	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	415898	shares
CY2019Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	415898	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	415898	shares
CY2019Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	415898	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4194000	USD
CY2019Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3826000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	219000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2087000	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	15505000	USD
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	40101000	USD
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7806000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1042000	USD
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	833000	USD
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	1977000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6879000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28720000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2440000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10259000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-392723000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-406422000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6814000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	861000	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	509000	shares
CY2018Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	603058	shares
CY2018Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	207000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	12000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2084000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	35216000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	22876000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	10433000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	1578000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-5854000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	-6069000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	4743000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	-143000	USD
CY2018Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0833
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8703626	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8688831	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20849083	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	16016515	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our condensed financial statements are prepared in accordance with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements and accompanying notes. An estimated loss contingency is accrued in our financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates and assumptions.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-19-013991-index-headers.html	Edgar Link	pending
0001628280-19-013991-index.html	Edgar Link	pending
0001628280-19-013991.txt	Edgar Link	pending
0001628280-19-013991-xbrl.zip	Edgar Link	pending
ex-106x20190930.htm	Edgar Link	pending
ex-107x20190930.htm	Edgar Link	pending
ex-311x20190930.htm	Edgar Link	pending
ex-312x20190930.htm	Edgar Link	pending
ex-321x20190930.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
rgls-20190930.xml	Edgar Link	completed
rgls-20190930.xsd	Edgar Link	pending
rgls-20190930_cal.xml	Edgar Link	unprocessable
rgls-20190930_def.xml	Edgar Link	unprocessable
rgls-20190930_lab.xml	Edgar Link	unprocessable
rgls-20190930_pre.xml	Edgar Link	unprocessable
rgls20190930-10q.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RGLS
Regulus Therapeutics Inc. Stock $rgls

2019 Q4 Form 10-Q Financial Statement

#000162828019013991 Filed on November 12, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGLS Regulus Therapeutics Inc. Stock $rgls

2019 Q4 Form 10-Q Financial Statement

#000162828019013991 Filed on November 12, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGLS
Regulus Therapeutics Inc. Stock $rgls